Caprospinol, formerly known as SP-233, is a β-Amyloid (Aβ) protein neurotoxicity inhibitor potentially for the treatment of Alzheimer's disease. Caprospinol crosses the blood-brain barrier, accumulates in the brain, and restores cognitive impairment in a pharmacological rat model of AD. Caprospinol is stable, does not bind to known steroid receptors, is devoid of mutagenic and genotoxic properties, and is devoid of acute toxicity in rodents. References: Papadopoulos V, Lecanu L. Caprospinol: discovery of a steroid drug candidate to treat Alzheimer's disease based on 22R-hydroxycholesterol structure and properties. J Neuroendocrinol. 2012 Jan;24(1):93-101. doi: 10.1111/j.1365-2826.2011.02167.x. Review. PubMed PMID: 21623958.

纯度：≥98%

CAS：4952-56-1